Market Place
Sourcing Support
ISA reports highlights of randomized Phase 2 cancer vaccine trial in neck cancer
12 Dec 2023 //
PR NEWSWIRE
ISA`s cancer vaccine fails in ph. 2, Regeneron loses interest
12 Dec 2023 //
FIERCE BIOTECH
First Patient with Chronic Hep B Dosed with ISA104 in First-in-Human Ph 1 Study
31 Aug 2023 //
PR NEWSWIRE
First patient dosed in phase 1 study for chronic hepatitis B treatment
31 Aug 2023 //
PHARMAFILE
The combination of ISA101b and Libtayo® shows promising results
06 Jun 2023 //
PR NEWSWIRE
ISA Pharmaceuticals to Present First Trial Data from Phase II Study of ISA101b
25 May 2023 //
PR NEWSWIRE
ISA to Present Pre-clinical Data on its Protective SLP Therapy SARS-CoV-2
27 Apr 2023 //
PR NEWSWIRE
ISA Pharma to Attend and Present at Upcoming Scientific and Business Conferences
20 Apr 2023 //
PR NEWSWIRE
ISA and Cancer Focus Fund Announce $5 Million Investment to Support ISA103
04 Jan 2023 //
PR NEWSWIRE
ISA concludes subject enrolment in HPV16 positive OPC therapy trial
01 Dec 2022 //
CLINICALTRIALSARENA
ISA`s Completes Enrolment in Randomized Double Blind Ph 2 Trial of ISA101
30 Nov 2022 //
PRNEWSWIRE
ISA Pharmaceuticals to Present at Business Conferences in May 2022
27 Apr 2022 //
PRNEWSWIRE
Long term study confirms efficacy of ISA`s T-cell activating immunotherapy
01 Mar 2022 //
PRNEWSWIRE
ISA Pharmaceuticals Receives Fast Track Designation for Lead Product ISA101b
14 Sep 2021 //
PRNEWSWIRE
ISA Pharmaceuticals Starts Third Phase 2 Clinical Trial of ISA101b and Libtayo
07 Sep 2021 //
PRNEWSWIRE
ISA Pharmaceuticals announces successful closing of EUR 26 million funding round
13 Jul 2021 //
PRNEWSWIRE
ISA Pharmaceuticals announces successful closing of EUR 26 million funding round
13 Jul 2021 //
PRNEWSWIRE
ISA Pharmaceuticals selects product candidate for clinical trial with first
03 Mar 2021 //
PRNEWSWIRE
ISA Pharmaceuticals Receives US Orphan-Drug Designation for ISA101b in HPV16
30 Jun 2020 //
PRNEWSWIRE
ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collab With Regeneron
17 Jun 2020 //
PR NEWSWIRE
ISA Pharma Strengthens Strategic Immuno-Oncology Collaboration Regeneron
17 Jun 2020 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.